Peripheral quantitative computed tomography is useful to monitor response to alendronate therapy in postmenopausal women

Journal of Bone and Mineral Metabolism

Volumn 27, Issue 2, 2009, Pages 175-181

  Sawada, Kenjiro ^a   Morishige, Ken Ichirou ^a   Nishio, Yukihiro ^b   Hayakawa, Jun ^a   Mabuchi, Seiji ^a   Isobe, Aki ^c   Ogata, Seiji ^a   Sakata, Masahiro ^a   Ohmichi, Masahide ^d   Kimura, Tadashi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA POLICE HOSPITAL   (Japan)

^c SAKAI MUNICIPAL HOSPITAL   (Japan)

^d OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Alendronate; Colles' fracture; Osteoporosis; Peripheral quantitative computed tomography

Indexed keywords

ALENDRONIC ACID; ALFACALCIDOL; CALCIUM; DEOXYPYRIDINOLINE;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE TURNOVER; CLINICAL ARTICLE; CLINICAL TRIAL; COLLES FRACTURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAPHYSIS; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; JAPANESE; LUMBAR SPINE; OSTEOPENIA; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RADIUS; RANDOMIZED CONTROLLED TRIAL; TRABECULAR BONE; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ABSORPTIOMETRY, PHOTON; ADULT; AGED; ALENDRONATE; AMINO ACIDS; BIOLOGICAL MARKERS; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; BONE REMODELING; FEMALE; HUMANS; LUMBAR VERTEBRAE; MIDDLE AGED; POSTMENOPAUSE; RADIUS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 60849137828     PISSN: 09148779     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00774-008-0025-7     Document Type: Article

References (24)

1. I Gorai K Nonaka H Kishimoto H Sakata Y Fujii T Fujita 2001 Cut-off values determined for vertebral fracture by peripheral quantitative computed tomography in Japanese women Osteoporos Int 12 741 748
2. DM Black SR Cummings LJ Melton III 1992 Appendicular bone mineral and a woman's lifetime risk of hip fracture J Bone Miner Res 7 639 646
3. MT Cuddihy SE Gabriel CS Crowson WM O'Fallon LJ Melton III 1999 Forearm fractures as predictors of subsequent osteoporotic fractures Osteoporos Int 9 469 475
4. JD Gay 1974 Radial fracture as an indicator of osteoporosis: a 10-year follow-up study Can Med Assoc J 111 156 157
5. DM Black SR Cummings DB Karpf JA Cauley DE Thompson MC Nevitt DC Bauer HK Genant WL Haskell R Marcus SM Ott JC Torner SA Quandt TF Reiss KE Ensrud Fracture Intervention Trial Research Group 1996 Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures Lancet 348 1535 1541
6. ML Bouxsein RA Parker SL Greenspan 1999 Forearm bone mineral densitometry cannot be used to monitor response to alendronate therapy in postmenopausal women Osteoporos Int 10 505 509
7. K Tsurusaki M Ito K Hayashi 2000 Differential effects of menopause and metabolic disease on trabecular and cortical bone assessed by peripheral quantitative computed tomography (pQCT) Br J Radiol 73 14 22
8. R Eastell 1998 Treatment of postmenopausal osteoporosis N Engl J Med 338 736 746
9. PF Schneider M Fischer B Allolio D Felsenberg U Schroder J Semler JR Ittner 1999 Alendronate increases bone density and bone strength at the distal radius in postmenopausal women J Bone Miner Res 14 1387 1393
10. ME Muller CE Webber JD Adachi 2003 Hormone replacement therapy improves distal radius bone structure by endocortical mineral deposition Can J Physiol Pharmacol 81 952 958
11. K Sawada K Morishige M Ohmichi Y Nishio T Yamamoto J Hayakawa S Mabuchi A Isobe H Sasaki M Sakata K Tasaka Y Murata 2007 Peripheral quantitative computed tomography (pQCT) is useful for monitoring bone mineral density of the patients who receive hormone replacement therapy Maturitas 56 343 349
12. K Sawada K-I Morishige T Yamamoto M Ohmichi Y Kanda K Takahashi K Tasaka Y Murata 2002 Comparison of pQCT and DXA to analyze treatment effect in postmenopausal osteoporosis Osteoporosis Jpn 10 465 468
13. MA Dambacher M Neff R Kissling L Qin 1998 Highly precise peripheral quantitative computed tomography for the evaluation of bone density, loss of bone density and structures Consequences for prophylaxis and treatment Drugs Aging 12 Supp 1 15 24
14. H Orimo Y Sugioka M Fukunaga Y Muto T Hotokebuchi 1998 Diagnostic criteria of primary osteoporosis J Bone Miner Metab 16 139 150
15. L Qin W Choy S Au M Fan P Leung 2007 Alendronate increases BMD at appendicular and axial skeletons in patients with established osteoporosis J Orthop Surg 2 9
16. M Shiraki K Kushida M Fukunaga H Kishimoto K Kaneda H Minaguchi T Inoue A Tomita Y Nagata M Nakashima H Orimo The Alendronate Research Group 1998 A placebo-controlled, single-blind study to determine the appropriate alendronate dosage in postmenopausal Japanese patients with osteoporosis Endocr J 45 191 201
17. T Nakamura K Kushida M Shiraki M Fukunaga M Taga H Kishimoto A Tomita T Inoue H Mizuguchi K Kaneda Y Nagata M Nakajima H Orimo 1998 Adose-finding study of alendronate tablets in women with involutional osteoporosis, postmenopausal bone loss and artificial menopause Shinryou To Shinyaku 35 3 17 (in Japanese)
18. PC de Groen DF Lubbe LJ Hirsch A Daifotis W Stephenson D Freedholm S Pryor-Tillotson MJ Seleznick H Pinkas KK Wang 1996 Esophagitis associated with the use of alendronate N Engl J Med 335 1016 1021
19. M Shiraki K Kushida M Fukunaga H Kishimoto M Taga T Nakamura K Kaneda H Minaguchi T Inoue H Morii A Tomita K Yamamoto Y Nagata M Nakashima H Orimo Treatment Research Group 1999 A double-masked multicenter comparative study between alendronate and alfacalcidol in Japanese patients with osteoporosis The Alendronate Phase III Osteoporosis Osteoporos Int 10 183 192
20. H Orimo M Shiraki Y Hayashi T Hoshino T Onaya S Miyazaki H Kurosawa T Nakamura N Ogawa 1994 Effects of 1 alpha-hydroxyvitamin D3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis Calcif Tissue Int 54 370 376
21. M Shiraki K Kushida K Yamazaki T Nagai T Inoue H Orimo 1996 Effects of 2 years' treatment of osteoporosis with 1 alpha-hydroxy vitamin D3 on bone mineral density and incidence of fracture: a placebo-controlled, double-blind prospective study Endocr J 43 211 220
22. SA Earnshaw SA Cawte A Worley DJ Hosking 1998 Colles' fracture of the wrist as an indicator of underlying osteoporosis in postmenopausal women: a prospective study of bone mineral density and bone turnover rate Osteoporos Int 8 53 60
23. HG Bone RW Downs Jr JR Tucci ST Harris RS Weinstein AA Licata MR McClung DB Kimmel BJ Gertz E Hale WJ Polvino Alendronate Elderly Osteoporosis Study Centers 1997 Dose-response relationships for alendronate treatment in osteoporotic elderly women J Clin Endocrinol Metab 82 265 274
24. JR Tucci RP Tonino RD Emkey CA Peverly U Kher AC Santora II 1996 Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosis Am J Med 101 488 501